Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A study including researchers in Nuffield Department of Population Health has found that government investment in healthcare research is good for the wider economy.

The research, supported by the NIHR Oxford Biomedical Research Centre (BRC), found that the return on investment in the Oxford BRC was 46% in terms of income and job creation alone.

The paper, ‘A macroeconomic assessment of the impact of medical research expenditure: A case study of NIHR Biomedical Research Centres’, was published in the Plos One journal.

There are a number of methodologies for measuring research impact; one that has been widely used is the Payback Framework, which aims to capture the full life-cycle of biomedical research, from the initial concept to the eventual health, economic and societal benefits.

However, finding the data this framework requires over lengthy time lags is a major difficulty and, conscious that health benefits may not be realised for several years, the Oxford researchers decided to focus on the shorter-term economic returns by using an input-output analysis framework, which is often used to assess the impact of major government spending projects on other aspects of regional economies.

Read more (NIHR Oxford Biomedical Research Centre website)

Similar stories

Long COVID: vaccination could reduce symptoms, new research suggests

While evidence suggests that people who are vaccinated before they get COVID are less likely to develop long COVID than unvaccinated people, the effectiveness of vaccination on existing long COVID has been less clear.

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.